Integer Holdings Corporation (ITGR)
USD 131.5
(-3.79%)
USD 131.5
(-3.79%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 418.28 Million USD | 16.51% |
| 2022 | 359 Million USD | 6.54% |
| 2021 | 336.97 Million USD | 17.94% |
| 2020 | 285.7 Million USD | -19.52% |
| 2019 | 355.01 Million USD | -2.11% |
| 2018 | 362.66 Million USD | -7.85% |
| 2017 | 393.55 Million USD | 4.03% |
| 2016 | 378.29 Million USD | 60.89% |
| 2015 | 235.13 Million USD | 1.61% |
| 2014 | 231.39 Million USD | 5.51% |
| 2013 | 219.31 Million USD | 8.76% |
| 2012 | 201.64 Million USD | 11.81% |
| 2011 | 180.35 Million USD | 3.9% |
| 2010 | 173.58 Million USD | 4.3% |
| 2009 | 166.41 Million USD | 6.82% |
| 2008 | 155.78 Million USD | 34.27% |
| 2007 | 116.02 Million USD | 13.26% |
| 2006 | 102.44 Million USD | 14.39% |
| 2005 | 89.55 Million USD | 10.94% |
| 2004 | 80.72 Million USD | -10.14% |
| 2003 | 89.82 Million USD | 26.7% |
| 2002 | 70.89 Million USD | 16.5% |
| 2001 | 60.85 Million USD | 24.65% |
| 2000 | 48.82 Million USD | 27.88% |
| 1999 | 38.17 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 100.38 Million USD | -8.95% |
| 2024 Q2 | 112.53 Million USD | 12.1% |
| 2024 Q3 | 116.56 Million USD | 3.59% |
| 2023 Q3 | 105.55 Million USD | -0.23% |
| 2023 FY | 418.28 Million USD | 16.51% |
| 2023 Q4 | 110.25 Million USD | 4.45% |
| 2023 Q1 | 96.67 Million USD | -1.27% |
| 2023 Q2 | 105.8 Million USD | 9.45% |
| 2022 Q1 | 81.47 Million USD | -0.48% |
| 2022 FY | 359 Million USD | 6.54% |
| 2022 Q4 | 97.91 Million USD | 12.91% |
| 2022 Q3 | 86.71 Million USD | -6.65% |
| 2022 Q2 | 92.89 Million USD | 14.02% |
| 2021 FY | 336.97 Million USD | 17.94% |
| 2021 Q3 | 81.87 Million USD | -7.75% |
| 2021 Q4 | 81.86 Million USD | -0.01% |
| 2021 Q1 | 84.48 Million USD | 15.4% |
| 2021 Q2 | 88.74 Million USD | 5.04% |
| 2020 Q4 | 73.2 Million USD | 26.37% |
| 2020 Q2 | 57.86 Million USD | -40.16% |
| 2020 Q1 | 96.7 Million USD | 27.19% |
| 2020 FY | 285.7 Million USD | -19.52% |
| 2020 Q3 | 57.93 Million USD | 0.12% |
| 2019 Q1 | 88.61 Million USD | 0.19% |
| 2019 Q4 | 76.03 Million USD | -18.59% |
| 2019 Q2 | 96.98 Million USD | 9.45% |
| 2019 Q3 | 93.38 Million USD | -3.71% |
| 2019 FY | 355.01 Million USD | -2.11% |
| 2018 FY | 362.66 Million USD | -7.85% |
| 2018 Q4 | 88.44 Million USD | -3.78% |
| 2018 Q3 | 91.92 Million USD | -6.93% |
| 2018 Q2 | 98.76 Million USD | 3.13% |
| 2018 Q1 | 95.77 Million USD | -8.63% |
| 2017 Q2 | 99.27 Million USD | 8.82% |
| 2017 Q3 | 98.23 Million USD | -1.04% |
| 2017 Q4 | 104.81 Million USD | 6.7% |
| 2017 FY | 393.55 Million USD | 4.03% |
| 2017 Q1 | 91.22 Million USD | -1.79% |
| 2016 FY | 378.29 Million USD | 60.89% |
| 2016 Q1 | 91.46 Million USD | 25.06% |
| 2016 Q2 | 96.03 Million USD | 4.99% |
| 2016 Q3 | 97.9 Million USD | 1.96% |
| 2016 Q4 | 92.89 Million USD | -5.13% |
| 2015 Q3 | 51.64 Million USD | -10.88% |
| 2015 Q1 | 52.39 Million USD | -8.42% |
| 2015 Q4 | 73.14 Million USD | 41.62% |
| 2015 FY | 235.13 Million USD | 1.61% |
| 2015 Q2 | 57.95 Million USD | 10.6% |
| 2014 Q3 | 58.11 Million USD | -0.6% |
| 2014 Q2 | 58.47 Million USD | 1.52% |
| 2014 Q1 | 57.59 Million USD | 0.37% |
| 2014 FY | 231.39 Million USD | 5.51% |
| 2014 Q4 | 57.21 Million USD | -1.56% |
| 2013 Q3 | 55.87 Million USD | -2.49% |
| 2013 FY | 219.31 Million USD | 8.76% |
| 2013 Q4 | 57.38 Million USD | 2.7% |
| 2013 Q2 | 57.3 Million USD | 17.54% |
| 2013 Q1 | 48.74 Million USD | -6.02% |
| 2012 Q3 | 50.95 Million USD | -1.89% |
| 2012 FY | 201.64 Million USD | 11.81% |
| 2012 Q2 | 51.93 Million USD | 10.76% |
| 2012 Q1 | 46.88 Million USD | 4.96% |
| 2012 Q4 | 51.87 Million USD | 1.81% |
| 2011 Q3 | 41.9 Million USD | -10.08% |
| 2011 FY | 180.35 Million USD | 3.9% |
| 2011 Q4 | 44.67 Million USD | 6.6% |
| 2011 Q2 | 46.6 Million USD | -1.2% |
| 2011 Q1 | 47.17 Million USD | 6.09% |
| 2010 FY | 173.58 Million USD | 4.3% |
| 2010 Q2 | 45.45 Million USD | 9.11% |
| 2010 Q1 | 41.66 Million USD | 0.04% |
| 2010 Q4 | 44.46 Million USD | 5.88% |
| 2010 Q3 | 41.99 Million USD | -7.62% |
| 2009 Q3 | 39.13 Million USD | -5.63% |
| 2009 FY | 166.41 Million USD | 6.82% |
| 2009 Q4 | 41.64 Million USD | 6.41% |
| 2009 Q2 | 41.47 Million USD | -6.1% |
| 2009 Q1 | 44.16 Million USD | -5.52% |
| 2008 Q4 | 46.74 Million USD | 11.95% |
| 2008 Q3 | 41.75 Million USD | 2.85% |
| 2008 Q2 | 40.59 Million USD | 52.05% |
| 2008 Q1 | 26.69 Million USD | 0.54% |
| 2008 FY | 155.78 Million USD | 34.27% |
| 2007 Q1 | 28.62 Million USD | 27.81% |
| 2007 Q2 | 31.7 Million USD | 10.77% |
| 2007 Q3 | 29.14 Million USD | -8.09% |
| 2007 Q4 | 26.55 Million USD | -8.87% |
| 2007 FY | 116.02 Million USD | 13.26% |
| 2006 FY | 102.44 Million USD | 14.39% |
| 2006 Q4 | 22.39 Million USD | -12.64% |
| 2006 Q3 | 25.63 Million USD | -7.56% |
| 2006 Q1 | 28.59 Million USD | 46.87% |
| 2006 Q2 | 27.73 Million USD | -3.0% |
| 2005 FY | 89.55 Million USD | 10.94% |
| 2005 Q4 | 19.46 Million USD | -19.49% |
| 2005 Q3 | 24.18 Million USD | -3.74% |
| 2005 Q2 | 25.11 Million USD | 20.84% |
| 2005 Q1 | 20.78 Million USD | 27.32% |
| 2004 FY | 80.72 Million USD | -10.14% |
| 2004 Q3 | 17.4 Million USD | -26.94% |
| 2004 Q4 | 16.32 Million USD | -6.18% |
| 2004 Q2 | 23.81 Million USD | 3.76% |
| 2004 Q1 | 22.95 Million USD | 14.94% |
| 2003 Q1 | 22.81 Million USD | 11.42% |
| 2003 FY | 89.82 Million USD | 26.7% |
| 2003 Q4 | 19.97 Million USD | -16.34% |
| 2003 Q3 | 23.87 Million USD | 3.03% |
| 2003 Q2 | 23.17 Million USD | 1.57% |
| 2002 Q2 | 15.59 Million USD | -2.21% |
| 2002 Q1 | 15.95 Million USD | 2.32% |
| 2002 FY | 70.89 Million USD | 16.5% |
| 2002 Q4 | 20.47 Million USD | 8.49% |
| 2002 Q3 | 18.87 Million USD | 20.98% |
| 2001 Q1 | 14.01 Million USD | -0.74% |
| 2001 FY | 60.85 Million USD | 24.65% |
| 2001 Q2 | 14.6 Million USD | 4.27% |
| 2001 Q3 | 16.64 Million USD | 13.96% |
| 2001 Q4 | 15.59 Million USD | -6.35% |
| 2000 Q3 | 9.72 Million USD | 0.0% |
| 2000 Q4 | 14.11 Million USD | 45.13% |
| 2000 FY | 48.82 Million USD | 27.88% |
| 1999 FY | 38.17 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Abbott Laboratories | 22.13 Billion USD | 98.11% |
| Allurion Technologies Inc. | 41.49 Million USD | -907.998% |
| Artivion, Inc. | 229.17 Million USD | -82.519% |
| Avanos Medical, Inc. | 379.7 Million USD | -10.163% |
| Butterfly Network, Inc. | 16.85 Million USD | -2381.544% |
| Butterfly Network, Inc. | 16.85 Million USD | -2381.544% |
| Bio-Rad Laboratories, Inc. | 1.43 Billion USD | 70.777% |
| Boston Scientific Corporation | 9.89 Billion USD | 95.773% |
| Perspective Therapeutics, Inc. | 1.63 Million USD | -25499.082% |
| CONMED Corporation | 643.06 Million USD | 34.954% |
| Edwards Lifesciences Corporation | 4.62 Billion USD | 90.956% |
| Paragon 28, Inc. | 172.79 Million USD | -142.078% |
| Glaukos Corporation | 239.13 Million USD | -74.917% |
| Globus Medical, Inc. | 1.02 Billion USD | 59.003% |
| Inspire Medical Systems, Inc. | 528.22 Million USD | 20.812% |
| Medtronic plc | 19.45 Billion USD | 97.85% |
| Nevro Corp. | 290.06 Million USD | -44.208% |
| Owlet, Inc. | 22.58 Million USD | -1751.902% |
| Penumbra, Inc. | 682.64 Million USD | 38.725% |
| Vicarious Surgical Inc. | -1.85 Million USD | 22661.435% |
| Smith & Nephew plc | 3.7 Billion USD | 88.698% |
| Sonendo, Inc. | 10.72 Million USD | -3801.222% |
| STERIS plc | 2.23 Billion USD | 81.276% |
| Stryker Corporation | 13.05 Billion USD | 96.797% |
| Vapotherm, Inc. | 28.28 Million USD | -1378.941% |
| Zimmer Biomet Holdings, Inc. | 5.31 Billion USD | 92.123% |